End-of-life choice means little without end-of-life support
A strong end-of-life care system does not wait until the final days to step in.
Newsletters and Deep Dive digital magazine
A strong end-of-life care system does not wait until the final days to step in.
Amgen's Lumykras will no longer be funded by the Cancer Drugs Fund for KRAS-mutated lung cancer, says NHS reimbursement authority NICE.
A phase 1/2 trial in AL amyloidosis saw 100% of patients obtaining at least a very good partial response with 90% obtaining a complete response.
With measles cases rising, the UK has launched a campaign urging around a million families to book the new four-in-one MMRV vaccine.
Women with endometriosis in England could be offered simple non-invasive tests for diagnosis of their condition, rather than a surgical procedure.
Editor's Picks
Newsletters and Deep Dive
digital magazine